Skip to main content

FDA Approved Immune Check Point Inhibiting Antibody Therapies That Target PD-1, PD-L1 or CTLA-4

Immune checkpoint inhibiting immunotherapies:
These are the class of monoclonal antibody therapies that prevents T-cell inhibition and promotes the activation and proliferation of effector T cells. Two such receptors CTLA-4 & PD-1 that are expressed in T cells transduce inhibitory signals after binding to its ligand. 
The monoclonal antibodies targeted against these receptors or their ligands have been shown to increase the tumor-killing activity of T cells. 
Figure 1: Immune Check Point Inhibiting Monoclonal Antibodies and its Target in T cells and Tumors. Pembrolizumab (Keytruda), Nivolumab (Opdivo), and cemiplimab (Libtayo) block PD-1 expressed in T cells. Atezolizumab (Tecentriq), Avelumab (Bavencio), and Durvalumab (Imfinzi) block PD-L1 expressed in tumor cells. Ipilimumab (Yervoy) blocks CTLA-4 antigen present in T cells
 

PD-1 inhibiting antibodies: 

These monoclonal antibodies block the PD-1 signaling by binding to its ligand PD-1 expressed in the T cells. Examples include
These monoclonal antibodies block the inhibitory PD-1 signaling by binding to its ligand PD-L1 expressed in the tumor cells. Examples include

CTLA-4 Inhibiting antibodies: 

These monoclonal antibodies block the inhibitory CTLA-4 signaling by binding to CTLA-4 expressed in the tumor cells. Example include

Indications of Immune Check Point Inhibiting Antibody Therapies

Immune checkpoint inhibiting antibody therapies have shown promise in the treatment of
  • Melanoma,
  • Small Non-Cell Lung Cancer, 
  • Urothelial Carcinoma, 
  • Renal Cell Carcinoma etc. 
Refer to prescribing information for the indication of each drug. 

Comments

  1. Your blog is very valuable which you have shared here about sublingual allergy immunotherapy I appreciate the efforts which you have put into this blog and also it is a gainful blog for us. Thank you for sharing this here.

    ReplyDelete

Post a Comment

Popular posts from this blog

Carbohydrate Metabolism: MCQs and answers on Glycolysis & Gluconeogenesis

                                      MCQ on Glycolysis & Gluconeogenesis 1) Which of the following enzyme is not involved in galactose metabolism? a) Glucokinase b) Galactokinase c) Galactose-1-Phosphate Uridyl transferase d) UDP-Galactose 4- epimerase 2) Which of the following enzyme is defective in galactosemia (type I) - a fatal genetic disorder in infants? a) Glucokinase b) Galactokinase c) Galactose-1-Phosphate Uridyl transferase d) UDP-Galactose 4- epimerase 3) In the liver, the accumulation of which of the following metabolite attenuates the inhibitory of ATP on phosphofructokinase? a) Glucose-6-Phosphate b) Citrate c) Fructose-1,6-Bisphosphate d) Fructose-2,6-Bisphosphate 4) Mutation in which of the following enzymes leads to a glycogen storage disease known as "Tarui’s disease"? a) Glucokinase b) Phosphofructokinase c) Phosphoglucomutase d) Pyruvate Kinase 5) E...

MCQs and Answers on cultivation (culture/incubation), Isolation and Identification of microorganisms: Medical Microbiology

40 plus questions - Multiple Choice Questions on Classification, Culture, and Identification of the microorganisms 1. Which of the following microorganism has the cocci cell shapes and sizes arranged usually in tetrad structures? a)  Streptococcus pneumoniae b)  Staphylococcus aureus c)  Chlamydia trachomatis d)  Neisseria meningitidis 2. What are the different growth morphology and cell structures used for the classification of fungi? Select all the correct answers: a) Yeast b) Mold c) Mycelia d) Protozoa 3. Which of the following media is formulated with additional nutrients to support the growth of fastidious or nutritionally demanding bacteria that may not grow well on basic media? a) Differential media b) Enriched media c) Nutrient agar (media) d) Selective media 4. Which of the following metabolic characteristic is a distinguishing characteristic and identification of colonies of  E. coli ? a) Hydrogen sulfide formation b) Indole Formation c) Lactose fe...

Multiple Choice Questions (MCQs) on Diabetes Mellitus: Pathogenesis, Diagnosis and Treatment

                                        MCQs on Diabetes mellitus 1) Diabetes mellitus is a disorder characterized by hyperglycemia.  Which of the following is not the common characteristic features of type 2 diabetes mellitus ? a) Impaired insulin secretion b) Increased Insulin resistance  c) Diabetic ketoacidosis d) Excessive hepatic glucose production 2) Which of the following are the characteristic features of type 1 diabetes mellitus? a) Type 1 diabetes is caused by an absolute deficiency of insulin. b) Type 1 diabetes is associated with the autoimmune destruction of beta cells.  c) Patients with  uncontrolled type 1 diabetes present with diabetic ketoacidosis d) All of the above   3) Which of the following serum measurements are not used for the diagnosis of diabetes mellitus? a) Fasting blood glucose d) Postprandial blood glucose  c) Insulin ...